These results suggest that the expression of H2A.Z.1 is up-regulated during hepatocarcinogenesis and that its high expression is associated with the biological process of tumorigenesis and poor prognosis of HCC patients. The gene discussed is H2AZ1; the disease is hepatocellular carcinoma.